New York State Common Retirement Fund Nurix Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 21,195 shares of NRIX stock, worth $485,789. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,195
Previous 25,372
16.46%
Holding current value
$485,789
Previous $530,000
10.19%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NRIX
# of Institutions
181Shares Held
68.1MCall Options Held
78KPut Options Held
53.8K-
Black Rock Inc. New York, NY6.82MShares$156 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.28MShares$98.1 Million6.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$92 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$89 Million0.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.87MShares$88.7 Million3.2% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $1.08B
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...